(19)
(11) EP 2 968 317 A1

(12)

(43) Date of publication:
20.01.2016 Bulletin 2016/03

(21) Application number: 14762460.5

(22) Date of filing: 17.03.2014
(51) International Patent Classification (IPC): 
A61K 31/497(2006.01)
C07D 471/04(2006.01)
A61K 31/519(2006.01)
(86) International application number:
PCT/US2014/030693
(87) International publication number:
WO 2014/145857 (18.09.2014 Gazette 2014/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 15.03.2013 US 201361794606 P
15.03.2013 US 201361852150 P
21.03.2013 US 201361803977 P
19.12.2013 US 201361918307 P

(71) Applicant: The Trustees of Columbia University in the City of New York
New York, New York 10027 (US)

(72) Inventors:
  • KARAYIORGOU, Maria
    Riverdale, NY 10471 (US)
  • MARKX, Sander
    Brooklyn, NY 11201 (US)
  • GOGOS, Joseph, A.
    Riverdale, NY 10471 (US)

(74) Representative: Atkinson, Jennifer 
Barker Brettell LLP 100 Hagley Road Edgbaston
Birmingham B16 8QQ
Birmingham B16 8QQ (GB)

   


(54) TARGETING THE mTOR PATHWAY IN NEUROLOGICAL DISEASE